Colgate-Palmolive Beheer
Beheer criteriumcontroles 3/4
De CEO Colgate-Palmolive is Noel Wallace, benoemd in Jul2018, heeft een ambtstermijn van 6.33 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 17.12M, bestaande uit 8.6% salaris en 91.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.05% van de aandelen van het bedrijf, ter waarde $ 38.21M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.3 jaar en 5.6 jaar.
Belangrijke informatie
Noel Wallace
Algemeen directeur
US$17.1m
Totale compensatie
| Percentage CEO-salaris | 8.6% |
| Dienstverband CEO | 6.3yrs |
| Eigendom CEO | 0.05% |
| Management gemiddelde ambtstermijn | 5.3yrs |
| Gemiddelde ambtstermijn bestuur | 5.6yrs |
Recente managementupdates
Recent updates
If EPS Growth Is Important To You, Colgate-Palmolive (NYSE:CL) Presents An Opportunity
Oct 26
Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now
Oct 25Colgate-Palmolive: Very Close To A Buy Following Recent Pullback
Oct 17Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)
Sep 30These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well
Sep 11Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down
Aug 27Colgate-Palmolive: Stability Pillar Reached Its Fair Value
Aug 19An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued
Aug 12Colgate-Palmolive: Good Growth Prospects Ahead
Aug 06Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)
Jul 11Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings
Jul 10Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite
Jun 23Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Jun 06Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital
May 21Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report
Apr 30Colgate-Palmolive: Loading Up Ahead Of Earnings
Apr 16Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E
Apr 02Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?
Feb 14Colgate-Palmolive: I'm Buying Before Interest Rates Decrease
Feb 14Colgate-Palmolive: Brushing Up Profits In Q4 2023
Jan 30Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult
Jan 01Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)
Dec 20Colgate-Palmolive Stock And Its Real Value
Nov 29Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On
Nov 14Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends
Nov 06Colgate-Palmolive: Own This Dividend King At The Right Price
Oct 31Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now
Oct 13Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Oct 02Colgate-Palmolive: Dividend King With Limited Growth
Sep 27An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued
Sep 11Colgate-Palmolive: Improving Prospects And A Reasonable Valuation
Sep 09Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World
Aug 16Colgate And The Importance Of Sales Growth, Expectations Matter
Aug 09Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business
Aug 03Colgate-Palmolive: Challenging Growth Prospects
Jul 10Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48
Jun 27Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48
Jun 13Colgate-Palmolive: The Reasons We Are Becoming More Cautious
Jun 05Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly
Jun 05Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$3b |
| Jun 30 2024 | n/a | n/a | US$3b |
| Mar 31 2024 | n/a | n/a | US$3b |
| Dec 31 2023 | US$17m | US$1m | US$2b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$2b |
| Dec 31 2022 | US$14m | US$1m | US$2b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$15m | US$1m | US$2b |
| Sep 30 2021 | n/a | n/a | US$3b |
| Jun 30 2021 | n/a | n/a | US$3b |
| Mar 31 2021 | n/a | n/a | US$3b |
| Dec 31 2020 | US$14m | US$1m | US$3b |
| Sep 30 2020 | n/a | n/a | US$3b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$3b |
| Dec 31 2019 | US$11m | US$1m | US$2b |
| Sep 30 2019 | n/a | n/a | US$2b |
| Jun 30 2019 | n/a | n/a | US$2b |
| Mar 31 2019 | n/a | n/a | US$2b |
| Dec 31 2018 | US$3m | US$891k | US$2b |
| Sep 30 2018 | n/a | n/a | US$2b |
| Jun 30 2018 | n/a | n/a | US$2b |
| Mar 31 2018 | n/a | n/a | US$2b |
| Dec 31 2017 | US$4m | US$821k | US$2b |
Compensatie versus markt: De totale vergoeding ($USD 17.12M ) Noel } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.74M ).
Compensatie versus inkomsten: De vergoeding van Noel is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Noel Wallace (60 yo)
6.3yrs
Tenure
US$17,121,584
Compensatie
Mr. Noel R. Wallace serves as Chief Executive Officer and Director of Colgate-Palmolive Company since April 2, 2019 and has been its President since July 11, 2018. Mr. Wallace serves as Chairman of Colgate...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 6.3yrs | US$17.12m | 0.050% $ 38.2m | |
| Chief Financial Officer | 4yrs | US$5.69m | 0.0045% $ 3.5m | |
| Chief Legal Officer & Secretary | 10yrs | US$4.23m | 0.0079% $ 6.0m | |
| Group President of Europe & Developing Markets | 5.3yrs | US$4.38m | 0.0075% $ 5.8m | |
| Group President of Growth & Strategy | 5.3yrs | US$4.52m | 0.0062% $ 4.7m | |
| Chief Technology Officer | 2.2yrs | geen gegevens | geen gegevens | |
| Chief Information Officer | 1.8yrs | geen gegevens | geen gegevens | |
| Chief Investor Relations Officer and Executive VP of M&A | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Global Ethics & Compliance | 5.8yrs | geen gegevens | geen gegevens | |
| Chief Human Resources Officer | 4.8yrs | geen gegevens | 0.0029% $ 2.2m | |
| President of Latin America Division | 5.3yrs | geen gegevens | geen gegevens | |
| President of Europe Division | 5.3yrs | geen gegevens | geen gegevens |
5.3yrs
Gemiddelde duur
59.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van CL is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.3 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 5.6yrs | US$17.12m | 0.050% $ 38.2m | |
| Independent Director | 19.1yrs | US$310.70k | 0.0040% $ 3.0m | |
| Independent Director | 8.7yrs | US$300.70k | 0.0026% $ 2.0m | |
| Independent Director | 5.7yrs | US$300.25k | 0.0014% $ 1.0m | |
| Lead Independent Director | 9.2yrs | US$333.44k | 0.00013% $ 99.4k | |
| Independent Director | 4.7yrs | US$310.94k | 0.00035% $ 267.5k | |
| Independent Director | 1.8yrs | US$262.81k | 0.00025% $ 191.1k | |
| Independent Director | 9.7yrs | US$310.70k | 0.00072% $ 550.4k | |
| Independent Director | 3.7yrs | US$308.44k | 0.0012% $ 917.3k | |
| Independent Director | less than a year | geen gegevens | 0.000010% $ 7.6k |
5.6yrs
Gemiddelde duur
63yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van CL wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.6 jaar).